Clinical Trial Update: Cryoablation Combined With Camrelizumab and Apatinib for Multiprimary Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating cryoablation combined with camrelizumab and apatinib for multiprimary lung cancer in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• Cryoablation

Snippet

Sponsor: ShiYue Li | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN